Butterworth Laboratories

butterworth-labs.co.uk

Excellence in Analytical Chemistry Since 1974 With 40 years experience, Butterworth Laboratories remains a fully independent UK contract analytical service providing Quality Control Testing, Method Development & Validation and Stability Study Storage & Testing to the pharmaceutical and related industries. We work in partnership with our clients who not only recognise our expertise in analytical chemistry and standards of service but also value our integrity and impartiality. Our regular inspections by the MHRA, UKAS and FDA ensure that the service you receive is at the very highest level for testing, validation and analysis.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

AIKIDO PHARMA ANNOUNCES STRATEGIC INTEREST IN ASP ISOTOPES INC.

AIkido Pharma Inc. | December 07, 2021

news image

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched isotopes. ASP Isotopes' Aerodynamic Separation Process is a method of enriching molybdenum-100 which is a stable isotope of molybdenum. Technetium-99m is the most used radioisotope in the nuclear imaging industry, but the supply chain, which involves the radioactive decay of molybdenum-99 has been fraught with problems dur...

Read More

BUSINESS INSIGHTS

TO PROVIDE SUITE OF CLINICAL TRIAL TECHNOLOGIES AND SERVICES, LABCORP RENEWED STRATEGIC PARTNERSHIP WITH MEDIDATA

Medidata | April 01, 2022

news image

A Dassault Systèmes company, Medidata, announced that Labcorp, a leading global life sciences company, has extended its 14-year partnership with Medidata, laying the groundwork for their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. “Our relationship with Medidata is built on using their core technologies to enhance our clinical trial portfolio and continue to expand our decentr...

Read More

PHARMACY MARKET

VALEMETOSTAT NEW DRUG APPLICATION SUBMITTED IN JAPAN FOR TREATMENT OF PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA

Daiichi Sankyo | December 29, 2021

news image

Daiichi Sankyo Company, Limited announced that it has submitted a New Drug Application to Japan’s Ministry of Health, Labour and Welfare for valemetostat, a potential first-in-class dual inhibitor of EZH1 and EZH2, for the treatment of patients with relapsed/refractory adult T-cell leukemia/lymphoma. ATL is a rare and aggressive type of peripheral T-cell lymphoma that occurs with greater frequency in parts of Japan and other regions.1,2 Patients with ATL face a poor prognosi...

Read More

PHARMA TECH

OVERLAND PHARMACEUTICALS PARTNERS WITH ARISGLOBAL TO ACCELERATE SAFETY CAPABILITIES

ArisGlobal | December 08, 2021

news image

ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® announced its partnership with Overland Pharmaceuticals. Overland, a premier biopharmaceutical company bringing innovative medicines to underserved patients in Asia and worldwide, selected ArisGlobal's LifeSphere Multivigilance program to centralize pharmacovigilance activities and further develop and commercialize advances i...

Read More
news image

PHARMACY MARKET

AIKIDO PHARMA ANNOUNCES STRATEGIC INTEREST IN ASP ISOTOPES INC.

AIkido Pharma Inc. | December 07, 2021

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched isotopes. ASP Isotopes' Aerodynamic Separation Process is a method of enriching molybdenum-100 which is a stable isotope of molybdenum. Technetium-99m is the most used radioisotope in the nuclear imaging industry, but the supply chain, which involves the radioactive decay of molybdenum-99 has been fraught with problems dur...

Read More
news image

BUSINESS INSIGHTS

TO PROVIDE SUITE OF CLINICAL TRIAL TECHNOLOGIES AND SERVICES, LABCORP RENEWED STRATEGIC PARTNERSHIP WITH MEDIDATA

Medidata | April 01, 2022

A Dassault Systèmes company, Medidata, announced that Labcorp, a leading global life sciences company, has extended its 14-year partnership with Medidata, laying the groundwork for their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. “Our relationship with Medidata is built on using their core technologies to enhance our clinical trial portfolio and continue to expand our decentr...

Read More
news image

PHARMACY MARKET

VALEMETOSTAT NEW DRUG APPLICATION SUBMITTED IN JAPAN FOR TREATMENT OF PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA

Daiichi Sankyo | December 29, 2021

Daiichi Sankyo Company, Limited announced that it has submitted a New Drug Application to Japan’s Ministry of Health, Labour and Welfare for valemetostat, a potential first-in-class dual inhibitor of EZH1 and EZH2, for the treatment of patients with relapsed/refractory adult T-cell leukemia/lymphoma. ATL is a rare and aggressive type of peripheral T-cell lymphoma that occurs with greater frequency in parts of Japan and other regions.1,2 Patients with ATL face a poor prognosi...

Read More
news image

PHARMA TECH

OVERLAND PHARMACEUTICALS PARTNERS WITH ARISGLOBAL TO ACCELERATE SAFETY CAPABILITIES

ArisGlobal | December 08, 2021

ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® announced its partnership with Overland Pharmaceuticals. Overland, a premier biopharmaceutical company bringing innovative medicines to underserved patients in Asia and worldwide, selected ArisGlobal's LifeSphere Multivigilance program to centralize pharmacovigilance activities and further develop and commercialize advances i...

Read More